Pensacola, FL (PRWEB) April 08, 2013
ActiGraph, a leading provider of objective physical activity and sleep/wake monitoring solutions for the global research community, announced today the release of an Application Programming Interface (API) to its popular ActiLife analysis software. The newest addition to ActiGraph’s growing technology suite, the ActiLife API was designed to run within closed systems, ensuring that protocol and regulation compliance requirements are not compromised during data collection.
ActiGraph’s new API allows programmatic control of the ActiLife software over a standard socket, allowing users to develop their own custom applications (Java, C#, C++, etc.) which can automate activity monitor deployments and downloads. An active Internet connection is not required and the ActiLife user interface control can be completely blocked from view, allowing full integration and automation of custom client applications. The ActiLife API currently supports all ActiGraph devices, including the company’s newest wireless wGT3X+ and wActiSleep+ monitors.
“The ActiLife API was primarily developed to support the implementation of ActiGraph’s objective monitoring system within drug trials and clinical research studies,” said Jeremy Wyatt, ActiGraph’s Vice President of Software Engineering. “The tremendous value of objective measures within these markets is finally becoming fully understood, and we are focused on developing tools, like the ActiLife API, that deliver data seamlessly in these complex environments.”
ActiGraph’s extensively validated suite of hardware and software products are widely used by prominent scientific and academic organizations in more than 72 countries in research studies and clinical trials involving physical activity, energy expenditure, and sleep/wake behavior and their relationships to a wide range of health conditions including obesity, diabetes, cancer, cardiovascular disease and sleep disorders. ActiGraph monitoring solutions have delivered objective activity and sleep data to many high profile population studies including the National Health and Nutrition Examination Survey (NHANES), the European Youth Health Study, the U.K. Millennium Cohort Study and the Harvard Women’s Health Study.